how long have glp 1 meds been around Chart: in 8 Americans Now Use GLP-1 Drugs for Weight Loss FAQ of the Month: Is

Higher-end projections are generally associated with cases involving confirmed, severe diagnoses, repeated emergency care, hospitalization, surgical intervention, or lasting disability, while lower-end projections tend to involve less intensive treatment or shorter symptom duration

Roughly 18-22% of patients report no subjective benefit

Key limitations include: No completed randomized controlled trials in humans Most data derived from animal models, limiting direct translatability Publication bias may favor positive results Long-term safety data in humans is not available Optimal dosing for human applications has not been established Effects of Oral Glutathione Supplementation on Systemic Oxidative Stress Biomarkers in Human Volunteers , published in Journal of Alternative and Complementary Medicine (Allen J and Bradley RD, 2011

This was mirrored by reduced MuSC senescence and increased mitochondrial respiration and membrane potential in MuSCs, paralleled by improved fitness and exercise performance

Theres also the issue most people are never told about: A significant part of the weight lost can be lean mass